Cellulose copolymer-based hydrogel as well as preparation and application thereof

By preparing cellulose copolymer hydrogels, the animal welfare and stability issues of existing scaffold materials are solved, providing a stable 3D cell culture environment that supports the three-dimensional structure and differentiation of cells, and is suitable for 3D cell culture, stem cell differentiation and organoid culture.

CN120818222APending Publication Date: 2025-10-21BEIJING GREEN MICRO & NANO TECHNOLOGY CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410894551.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2024-04-15
Filing Date
2024-07-04
Publication Date
2025-10-21

AI Technical Summary

Technical Problem

Existing 3D cell culture scaffold materials, such as Matrigel, have issues related to animal welfare, large batch-to-batch variability, unstable composition, and high temperature sensitivity, making it difficult to meet the needs of efficient and stable cell culture.

Method used

A cellulose-based hydrogel with a particle size of 1μm-50μm was prepared by using a cellulose copolymer or its derivative to form a hydrogel, which is then used as a cell culture medium by preparing an ordered three-dimensional micro-nano structure. Cellulose was dissolved using an ionic liquid and a NaOH/Urea system, and then pulverized.

Benefits of technology

It provides a stable and controllable cell culture environment that simulates the in vivo microenvironment, supports the three-dimensional structure of cells and their natural proliferation and differentiation, and solves the defects of existing scaffold materials. It is suitable for 3D cell culture, stem cell differentiation and organoid culture.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN120818222A_ABST
    Figure CN120818222A_ABST
Patent Text Reader

Abstract

The invention relates to a cellulose-based hydrogel prepared based on a cellulose copolymer, a cellulose derivative copolymer or a blend thereof, ultramicro fibers of cellulose form a net structure, and the cellulose-based hydrogel has a highly-ordered three-dimensional micro-nano structure, is better in transparency and is more beneficial to observation of a cell state. The cellulose-based hydrogel is suitable for culture of 3D cell culture tissues and organoids, the stem cells cultured by the cellulose-based hydrogel can form cluster culture stem cells and organoids, the operation is simple, compact fused monolayer endoderm cells are formed, non-directional differentiation of the stem cells can be inhibited, and the formed organoids are thick in vesicle wall and are in a solid shape. And the obtained product is a differentiated mature organ and can be used for high-throughput drug screening, drug toxicity testing and regenerative medicine.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] This application claims priority to prior applications filed with the State Intellectual Property Office of China on April 15, 2024, with patent application number 202410450788.X, entitled “A Cellulose Copolymer Hydrogel, Its Preparation, and Its Application in 3D Cell Culture”; patent application number 202410450790.7, entitled “A Cellulose Copolymer Culture Fluid and Its Application in Cultivating Tissues or Organoids”; and patent application number 202410450791.1, entitled “A Cellulose Copolymer Culture Fluid for Cultivating Stem Cells and Organoids, and Its Application.” The entire contents of each of the prior applications are incorporated herein by reference. Technical Field

[0002] The present invention belongs to the field of biotechnology and relates to a cellulose copolymer-based hydrogel liquid and a preparation method and application thereof, and specifically relates to a cellulose copolymer-based hydrogel, a culture medium for 3D cell culture, a culture medium for tissue and organoid culture or a culture medium for stem cell culture and its induced differentiation organoid, a kit and a preparation method and application thereof. Background Art

[0003] Conventional 2D cell culture often does not conform to the in vivo situation because cells gradually lose their original characteristics as they proliferate in a changed environment in vitro. Animal experiments are conducted entirely in vivo, but they become complicated due to the constraints of multiple factors in the body and the mutual influence between the internal and external environments. It is difficult to study a single process and it is difficult to study intermediate processes.

[0004] 3D cell culture technology is a technology between monolayer cell culture and animal experiments. It can simulate the in vivo environment to the greatest extent possible while showing the advantages of intuitive cell culture and controllable conditions. 3D cell culture can make up for many defects in the monolayer cell culture process, such as:

[0005] (1) 3D cell models can well simulate the cellular microenvironment in the body: gases, nutrients, metabolites and other substances show gradient concentration changes.

[0006] (2) 3D cell models can well simulate cell-cell interactions: three-dimensional cell-cell contacts and direct or indirect cell-cell communication.

[0007] (3) 3D cell models can well simulate the biochemical and physiological responses of cells: the responses of cells to internal or external stimuli are more consistent with real in vivo responses.

[0008] The difficulty of 3D cell culture technology is to ensure the three-dimensional structure of cells and maintain natural proliferation and differentiation activity. With decades of continuous development, the methods of 3D cell culture have also been constantly innovating, and the commonly used methods are mainly divided into two types: scaffold-based 3D cell culture methods and scaffold-free 3D cell culture methods. The scaffold-based 3D cell culture method has a long history of development and is supported by a large amount of literature. The materials used for cell culture scaffolds include agarose, collagen, fibronectin, gelatin, laminin, etc. These composite materials simulate the natural extracellular matrix (ECM) through porosity, fiber, permeability and mechanical stability, and can well simulate the interactions between cells and the interactions between cells and extracellular matrix in the in vivo environment, while allowing cells to aggregate, proliferate and migrate on the scaffold.

[0009] Stem cells are a type of cell with the potential to proliferate and differentiate, capable of developing into specific cell types in various tissues and organs. Stem cells can be categorized as totipotent, pluripotent, multipotent, and unipotent. Pluripotent stem cells can differentiate into all cells from the three germ layers, forming all tissues and organs. They are used for repair of various tissues and organs, disease treatment, and drug screening, making them a hot topic in stem cell research. Cultured stem cells are also used to form, maintain, and expand organoids. Embryonic stem cells (ECs) and induced pluripotent stem cells (iPSCs) are the most studied pluripotent stem cells. However, developing stem cells is not simple. A major challenge lies in how to effectively differentiate stem cells into cells with different functions. The stem cell microenvironment controls the differentiation of stem cells into functional cells, but our understanding of the molecular mechanisms is limited. A suitable and stable microenvironment is crucial for the cultivation and application of stem cells such as iPSCs.

[0010] Organoids are three-dimensional, stem-cell-derived cell populations that possess the multicellular, self-renewing characteristics of living tissue. Tumor organoids closely resemble a patient's tumor in terms of their tissue structure, cell types, and genetic profile. They can serve as surrogate models for drug testing and are amenable to passage and expansion. They maintain genomic stability and tumor heterogeneity, mimicking the tumor microenvironment and addressing the shortcomings of traditional cell and animal models.

[0011] Take Matrigel, a commonly used scaffold material, for example. This material is extracted from EHS mouse tumors, which are rich in extracellular matrix proteins. Its main components include laminin, type IV collagen, heparan sulfate glycoprotein, and entactin, as well as various growth factors and matrix metalloproteinases. At room temperature, Matrigel polymerizes to form a biologically active three-dimensional matrix that mimics the structure, composition, physical properties, and function of the in vivo cell basement membrane. This facilitates in vitro cell culture and differentiation, and can be used to study cell morphology, biochemical function, migration, invasion, and gene expression.

[0012] The current problems with basement membrane matrix gel include: 1) supply shortages due to animal welfare issues; 2) large and difficult to control batch-to-batch differences, with the nutrients and protein content greatly affected by batches; 3) animal-derived proteins and nucleic acids interfere with downstream experiments such as efficacy evaluation and fluorescence detection; and 4) the temperature-sensitive nature of the matrix gel itself places strict temperature requirements on storage and operation. Summary of the Invention

[0013] In order to solve the above technical problems, the present invention provides the following technical solutions:

[0014] A cellulose-based hydrogel formed from a cellulose copolymer, a cellulose derivative copolymer, or a blend thereof, wherein the matrix comprises the cellulose copolymer, the cellulose derivative copolymer, or a blend thereof, the matrix comprises a network structure composed of ultrafine cellulose derivative fibers, and the network structure comprises an ordered three-dimensional micro-nanostructure, the cellulose copolymer is a graft copolymer, the cellulose derivative copolymer is a graft copolymer of a cellulose derivative, and the blend comprises at least two or more of the above-mentioned cellulose copolymers and cellulose derivative copolymers.

[0015] According to an embodiment of the present invention, the diameter of the fiber is 0.01 μm to 0.10 μm, for example, 0.01 μm, 0.02 μm, 0.03 μm, 0.04 μm, 0.05 μm, 0.06 μm, 0.07 μm, 0.08 μm, 0.09 μm or 0.10 μm.

[0016] According to an embodiment of the present invention, the overall particle size of the matrix in the hydrogel is 1 μm-50 μm, for example, 1 μm, 5 μm, 8 μm, 10 μm, 15 μm, 20 μm, 25 μm, 30 μm, 35 μm, 40 μm, 45 μm or 50 μm.

[0017] According to an embodiment of the present invention, the solid content of the hydrogel is 0.1-3.0 wt%, for example, 0.1 wt%, 0.5 wt%, 1 wt%, 1.5 wt%, 2 wt%, 2.5 wt% or 3.0 wt%.

[0018] According to an embodiment of the present invention, the cellulose-based hydrogel is obtained by the following method, including first preparing a cellulose copolymer, a cellulose derivative copolymer or a blend thereof, referred to as the product, from cellulose or a cellulose derivative as a raw material, and then dispersing the product in pure water, or pouring the product solution into a coagulation bath to form a gel, and crushing the gel by a homogenizer, a colloid mill or a ball mill to obtain the cellulose-based hydrogel having a network structure with an ordered three-dimensional micro-nanostructure.

[0019] According to an embodiment of the present invention, the cellulose raw material includes microcrystalline cellulose, wood pulp cellulose, refined cotton, cotton pulp, or wood pulp, and the cellulose raw material or cellulose derivative raw material is dissolved in a cellulose solvent. According to an embodiment of the present invention, the solvent used in the coagulation bath can include water, ethanol, acetone, ethylene glycol, etc.

[0020] According to an embodiment of the present invention, the cellulose solvent, i.e., the solvent capable of dissolving cellulose, the cellulose-dissolving solvent system is selected from the ionic liquid and / or the NaOH / Urea system; more preferably, the cellulose-dissolving ionic liquid is selected from one or more of [AMIM][Cl], [BMIM][Cl], [EMIM][Ac], and [BMIM][Ac].

[0021] According to an embodiment of the present invention, the graft copolymer is selected from cellulose grafted biodegradable polyester (such as grafted polylactic acid, grafted polycaprolactone, grafted polyadipate, etc.), cellulose grafted polyethylene glycol, cellulose grafted polyurethane, cellulose grafted cyclodextrin, cellulose grafted monosaccharide / disaccharide / polysaccharide, cellulose grafted polyacrylamide, cellulose grafted poly(meth)acrylic acid, cellulose grafted polymethyl (meth)acrylate, cellulose grafted polystyrene or cellulose grafted polyester, etc.

[0022] According to an embodiment of the present invention, the graft copolymer of the cellulose derivative is, for example, cellulose acetate grafted polylactic acid, cellulose acetate grafted polycaprolactone, cellulose propionate grafted polyethylene carbonate, cellulose butyrate grafted polypropylene carbonate or cellulose acetate grafted polydioxanone.

[0023] According to an embodiment of the present invention, the cellulose copolymer, cellulose derivative copolymer or blend thereof is selected from cellulose ester grafted polylactic acid, cellulose acetate grafted polycaprolactone, cellulose propionate grafted polyethylene carbonate, cellulose butyrate grafted polypropylene carbonate or cellulose acetate grafted polydioxanone.

[0024] A method for preparing the above-mentioned cellulose-based hydrogel comprises the following steps:

[0025] 1) preparing a cellulose copolymer, a cellulose derivative copolymer or a blend thereof from cellulose or a cellulose derivative as a raw material, hereinafter referred to as the product;

[0026] 2) dispersing the product of step 1) in pure water, or pouring the product solution into a coagulation bath, washing with pure water, and then crushing the obtained cellulose-based hydrogel using a grinder, a colloid mill, a high-pressure homogenizer, etc. Specifically, the crushing is performed until the overall particle size of the matrix is ​​1 μm-50 μm, for example, 1 μm, 5 μm, 8 μm, 10 μm, 15 μm, 20 μm, 25 μm, 30 μm, 35 μm, 40 μm, 45 μm or 50 μm, to obtain the cellulose-based hydrogel having a network structure with an ordered three-dimensional micro-nanostructure.

[0027] According to an embodiment of the present invention, in step 1), the cellulose includes microcrystalline cellulose, wood pulp cellulose, refined cotton, cotton pulp or wood pulp.

[0028] According to an embodiment of the present invention, in step 1), the cellulose is dissolved in a cellulose solvent, and the cellulose solvent is any good solvent known in the art that can dissolve (including complete dissolution and partial dissolution) cellulose. Preferably, the cellulose solvent can be selected from one or more of the following systems: copper ammonia solution, copper ethylenediamine solution, organic solvent, ionic liquid, mixed solvent of ionic liquid and organic solvent, choline-type ionic liquid deep eutectic solvent system, organic solvent / salt system, amine oxide system (NMMO), carbamate system, alkali / water system, alkali / urea system, alkali / thiourea system, liquid ammonia / NH4SCN, organic acid, aqueous solution of metal salt, alcohol solution of metal salt hydrate, water-alcohol mixed solution of metal salt hydrate, and the like solvent system.

[0029] The organic solvent may be selected from one or more of N,N-dimethyl sulfoxide (DMSO), N,N-dimethylformamide (DMF), N,N-dimethylacetamide (DMAc), N-methyl-2-pyrrolidone (NMP), N-methylimidazole, imidazole, pyridine, ethylenediamine, hexafluoroacetone, hexafluoroisopropanol, glycerol, methyl isobutyl ketone, tetrahydrofuran, dioxane, and γ-valerolactone (GVL).

[0030] The organic solvent / salt system can be selected from one or more of N,N-dimethylacetamide / lithium chloride (DMAc / LiCl) system, N-methyl-2-pyrrolidone / NMP, and N,N-dimethyl sulfoxide / tetrabutylammonium fluoride system (DMSO / TBAF).

[0031] The alkali / water system can be selected from one or both of NaOH / H2O and KOH / H2O.

[0032] Wherein, the alkali / urea system can be selected from NaOH / Urea.

[0033] Wherein, the alkaline / thiourea system is selected from NaOH / thio-urea.

[0034] The organic acid can be selected from one or more of formic acid, acetic acid, propionic acid, butyric acid, succinic acid, lactic acid, glutamic acid, glycine, dichloroacetic acid, trichloroacetic acid, and toluenesulfonic acid.

[0035] Among them, the metal salt aqueous solution is preferably selected from aqueous solutions of metal salts such as CaCl2, ZnCl2, LiClO4, Ca(SCN)2, and LiSCN.

[0036] The alcohol solution of the metal salt hydrate can be selected from a methanol solution of CaBr2·H2O and a methanol solution of CaCl2·2H2O.

[0037] The water-alcohol mixed solution of the metal salt hydrate can be selected from a methanol aqueous solution of CaBr2·H2O and a methanol aqueous solution of CaCl2·2H2O.

[0038] The amine oxide system may be a NMMO / H2O / DMSO system, a NMMO / H2O / diethyltriamine system, or a NMMO / H2O system.

[0039] The ionic liquid is selected from an organic molten salt formed by cations and anions with a melting point lower than 100° C., preferably an organic molten salt that can dissolve the biomass natural polymer.

[0040] For example, the cation of the ionic liquid is selected from one or more substituted or unsubstituted imidazole, pyridine, pyrrole, amine, phosphine, choline, diazabicyclic, amino acid type cations; for example, the substituent can be C 1-6 Alkyl, C 1-6 One or more of alkenyl, phenyl or substituted phenyl; preferably one or more of methyl, ethyl, butyl and allyl;

[0041] Preferably, the cation is selected from one or more of the following cations: 1-ethyl-3-methylimidazolium cation ([EMIM]), 3-methylimidazolium cation ([MIM]), 1-propyl-3-methylimidazolium cation ([PMIM]), 1-allyl-3-methylimidazolium cation ([AMIM]), 1-butyl-3-methylimidazolium cation ([BMIM]), 1-butyl-2,3-dimethylimidazolium cation ([BMMIM]), 1,3-dimethylimidazolium cation ([MMIM]), 1-methoxyethyl-3-methylimidazolium cation ([MeOEMIM]), 1-methoxymethyl-3-methylimidazolium cation ([MeOMMIM]), 1-hydroxy-3-methylimidazolium cation ([HMIM]), 1-(2-hydroxyethyl)-3-methylimidazolium cation ([HOEMIM]), 1-methyl-3-benzylimidazolium cation ([MBzIM]), 1 cations include 1-pentyl-3-methylimidazolium cation ([PeMIM]), 1-benzyl-3-methylimidazolium cation ([BzMIM]), 1-m-methoxybenzyl-3-methylimidazolium cation ([MeOBzMIM]), 1-m-methylbenzyl-3-methylimidazolium cation ([MeBzMIM]), N-methylpyridinium cation ([MPyr]), N-ethylpyridinium cation ([EPyr]), N-butylpyridinium cation ([BPyr]), N-n-hexylpyridinium cation ([HPyr]), 1-butyl-3-methylpyrrolidinium ion ([BMPyrr]), tris(2-hydroxyethyl)methylamine ([THEMA]), tetrabutylamine ([TBA]), tetrabutylphosphine ([PBu4]), glycine cation ([Gly]), choline cation ([Ch]), and 1,5-diazabicyclo[4.3.0]one-5-ene ([DBNH]).

[0042] More preferably, the cation is selected from one or more of the following cations: 1-ethyl-3-methylimidazolium cation ([EMIM]), 1-allyl-3-methylimidazolium cation ([AMIM]), 1-butyl-3-methylimidazolium cation ([BMIM]), choline cation ([Ch]).

[0043] For example, the anion is selected from one or more of halogen anions, organic acid radical ions, organic acid ester anions, amino acid type anions, and the like.

[0044] Preferably, the anion is selected from one or more of the following anions: chloride ([Cl]), bromide ([Br]), fluoride ([F]), formate ([HCOO]), acetate ([CH3COO] or [Ac]), glycolate ([HOCH2COO]), propionate ([CH3CH2COO] or [OPr]), butyrate ([CH3CH2CH2COO] or [OBu]), octanoate ([Oct]), benzoate ([C6H5COO] or [PhCOO]), lactate ([CH3CH(OH)COO] or [Lac]), thioglycolate ([HSCH2COO]) , hexafluorophosphate ion ([PF6]), trifluoroborate ([BF3]), methyl phosphate ion ([(MeO)HPO2] or [MP]), dimethyl phosphate ion ([(MeO)2PO2] or [DMP]), diethyl phosphate ion ([(EtO)2PO2] or [DEP]), methyl sulfonate anion ([MeOSO3]), trifluoromethylsulfonate anion ([CF3SO3]), glycine anion ([Gly]), lysine anion ([Lys]), valine anion ([Val]), dicyanamide anion ([N(CN)2] or [DCA]), bistrifluoromethylsulfonimide ([Tf2N]) and the like anion or more.

[0045] More preferably, the anion is selected from one or more of the following anions: chloride ion ([Cl]), formate ion ([HCOO]), acetate ion ([Ac]), methyl phosphate ion ([(MeO)HPO2] or [MP]), dimethyl phosphate ion ([(MeO)2PO2] or [DMP]) and dicyanamide anion ([N(CN)2] or [DCA]).

[0046] According to an embodiment of the present invention, the ionic liquid can be selected from one or more of the following ionic liquids: 1-ethyl-3-methylimidazolium chloride ionic liquid ([EMIM][Cl]), 1-ethyl-3-methylimidazolium bromide ionic liquid ([EMIM][Br]), 1-ethyl-3-methylimidazolium formate ionic liquid ([EMIM][HCOO]), 1-ethyl-3-methylimidazolium acetate ionic liquid ([EMIM][Ac]), 1-ethyl-3-methylimidazolium octanoate ionic liquid ([EMIM][Oct]), 1-ethyl-3-methylimidazolium methyl phosphate ionic liquid ([EMIM][MP]), 1-ethyl-3-methylimidazolium dimethyl phosphate ionic liquid ([EMIM][MP]), 1-ethyl-3-methylimidazolium ... methyl phosphate ionic liquid ([EMIM][Ac]), 1-ethyl-3-methylimidazolium methyl phosphate ionic liquid ([EMIM][MP]), 1-ethyl-3-methylimidazol ionic liquids ([EMIM][DMP]), 1-ethyl-3-methylimidazolium diethyl phosphate ionic liquid ([EMIM][DEP]), 1-ethyl-3-methylimidazolium propionate ionic liquid ([EMIM][OPr]), 1-ethyl-3-methylimidazolium top ionic liquid ([EMIM][OBu]), 1-ethyl-3-methylimidazolium glycinate ionic liquid ([EMIM][Gly]), 1-ethyl-3-methylimidazolium lysine ionic liquid ([EMIM][Lys]), 1-allyl-3-methylimidazolium chloride ionic liquid ([AMIM][Cl]), 1-allyl-3-methylimidazolium bromide ionic liquid ([AMIM][Br]), 1-allyl-3-methylimidazolium formate ionic liquid ([AMIM][HCOO]), 1-allyl-3-methylimidazolium acetate ionic liquid ([AMIM][Ac]), 1-butyl-3-methylimidazolium chloride ionic liquid ([BMIM][Cl]), 1-butyl-3-methylimidazolium bromide ionic liquid ([BMIM][Br]), 1-butyl-3-methylimidazolium formate ionic liquid ([BMIM][HCOO]), 1-butyl-3-methylimidazolium acetate ionic liquid ([BMIM][Ac]), 1-butyl-3-methylimidazolium glycolate ionic liquid ([BMIM][HOCH2COO]), 1-butyl-3-methylimidazolium propionate ionic liquid Liquid ([BMIM][CH3CH2COO]), 1-butyl-3-methylimidazolium lactate ionic liquid [BMIM][Lac], 1-butyl-3-methylimidazolium butyrate ionic liquid ([BMIM][CH3CH2CH2COO]), 1-butyl-3-methylimidazolium benzoate ionic liquid ([BMIM][C6H5COO]), 1-butyl-3-methylimidazolium glycine salt ionic liquid ([BMIM][H2NCH2COO]), 1-butyl-3-methylimidazolium dicyanamide ionic liquid ([BMIM][N(CN)2]), 1-butyl-3-methylimidazolium bis(trifluoromethylsulfonyl)imide ionic liquid ([BMIM][Tf2N]),1-Butyl-3-methylimidazolium hexafluorophosphate ionic liquid ([BMIM][PF6]), 1-Butyl-3-methylimidazolium tetrafluoroborate ionic liquid ([BMIM][BF4]), 1-Butyl-3-methylimidazolium methanesulfonate ionic liquid ([BMIM][MeOSO3]), 1-Butyl-3-methylimidazolium trifluoromethanesulfonate ionic liquid ([BMIM][CF3SO3]), 1-Butyl-2,3-dimethylimidazolium tetrafluoroborate ionic liquid,

[0047] ([BMMIM][BF4]), 3-methylimidazolium formate ionic liquid ([MIM][HCOO]), 1,3-dimethylimidazolium chloride ionic liquid ([MMIM][Cl]), 1,3-dimethylimidazolium methyl phosphate ionic liquid ([MMIM][MP]), 1,3-dimethylimidazolium dimethyl phosphate ionic liquid ([MMIM][DMP]), 1,3-dimethylimidazolium methyl sulfonate ionic liquid ([MMIM][MeOSO3]), 1-hydroxy-3-methyl-imidazolium chloride ionic liquid ([HMIM][Cl]), 1-hydroxy-3-methyl-imidazolium trifluoromethylsulfonate ionic liquid ([HMIM] [CF3SO3]), 1-(2-hydroxyethyl)-3-methylimidazolium chloride ionic liquid ([HOEMIM][Cl]), 1-methoxymethyl-3-methylimidazolium bromide ionic liquid ([MeOMMIM][Br]), 1-methoxyethyl-3-methylimidazolium bromide ionic liquid ([MeOEMIM][Br]), N-ethylpyridinium chloride ionic liquid ([EPyr][Cl]), N-ethylpyridinium bromide ionic liquid ([EPyr][Br]), N-methylpicolinate ionic liquid ([MPyr][HCOO]), tris(2-hydroxyethyl)methylamine acetate ionic liquid ([THEMA][Ac]), tris(2-hydroxyethyl)methylamine acetate ionic liquid ([THEMA][Ac]), ) methylamine methanesulfonate ionic liquid ([THEMA][MeOSO3]), tris(2-hydroxyethyl)methylamine trifluoromethanesulfonate ionic liquid [THEMA][CF3SO3], tetrabutylphosphine valine ionic liquid [PBu4][Val], tetrabutylphosphine lysine ionic liquid [PBu4][Lys], tetrabutylphosphine glycinate ionic liquid [PBu4][Gly], 1-benzyl-3-methylimidazolium chloride ionic liquid ([BzMIM][Cl]), 1-benzyl-3-methylimidazolium dicyanamide ionic liquid ([BzMIM][DCA]), 1-m-methylbenzyl-3-methylimidazolium chloride ionic liquid ([M eBzMIM][Cl]), 1-m-methoxybenzyl-3-methylimidazolium chloride ionic liquid ([MeOBzMIM][Cl]), choline chloride ionic liquid ([Ch][Cl]), choline bromide ionic liquid (Ch][Br]), choline acetate ionic liquid ([Ch][CH3COO]), choline propionate ionic liquid ([Ch][CH3CH2COO]), choline butyrate ionic liquid ([Ch][CH3CH2CH2COO]), glycine hydrochloride ionic liquid ([Gly][Cl]), 1,5-diazabicyclo[4.3.0]keto-5-ene acetate ionic liquid ([DBNH][Ac]), etc.

[0048] Preferably, the choline-type deep eutectic solvent system is selected from one or more of [Ch][Cl] / urea, [Ch][Br] / urea, [Ch][Cl] / thio-urea, [Ch][Cl] / glycerol, and [Ch][Cl] / lactic acid.

[0049] Preferably, the solvent system for dissolving cellulose is selected from the ionic liquid and / or NaOH / Urea system; more preferably, the cellulose-dissolving ionic liquid is selected from one or more of [AMIM][Cl], [BMIM][Cl], [EMIM][Ac], and [BMIM][Ac].

[0050] According to an embodiment of the present invention, in step 1), the cellulose derivative includes cellulose ester, cellulose ether, cationized cellulose, anionized cellulose or oxidized cellulose.

[0051] According to an embodiment of the present invention, in step 2), the solvents that can be used in the coagulation bath include water, ethanol, acetone, ethylene glycol, etc.

[0052] According to an embodiment of the present invention, in step 2), the crushing is followed by a high-pressure sterilization step, and then the culture medium for 3D cell culture is prepared.

[0053] The present invention also provides a culture medium for 3D cell culture, which comprises the above-mentioned cellulose-based hydrogel and a basic culture medium, wherein the matrix of the cellulose-based hydrogel is a cellulose copolymer, a cellulose derivative copolymer or a blend thereof.

[0054] According to an embodiment of the present invention, the basal culture medium can be selected from basal culture medium known in the art. For example, the basal culture medium includes DMEM / F12 (GIBCO / 10565018), 10% FBS (GIBCO / 10091-148) and 1% P / S

[0055] (GIBCO / 15140122).

[0056] According to an embodiment of the present invention, the cellulose-based hydrogel has the meaning as described above.

[0057] The present invention also provides a method for preparing the above-mentioned culture solution, which comprises the following steps:

[0058] S1: preparing the above-mentioned cellulose-based hydrogel;

[0059] S2: The cellulose-based hydrogel in step S1 is mixed with a basic culture medium to prepare the culture medium for 3D cell culture.

[0060] According to an embodiment of the present invention, in step S2, the volume ratio of the cellulose-based hydrogel to the basic culture medium is 1-10:1-10, for example, 1:1, 1:5, 1:10, 5:1 or 10:1.

[0061] The present invention also provides use of the culture solution in 3D cultured cells.

[0062] The present invention also provides a method for 3D cell culture, which is carried out in the above-mentioned 3D cell culture medium.

[0063] According to an embodiment of the present invention, the 3D culture method comprises the following steps:

[0064] a) Preparing a cell suspension: uniformly mixing the culture medium for 3D cell culture with the cells to obtain a cell suspension;

[0065] b) 3D culture: The cell suspension from step a) is cultured in an incubator.

[0066] According to an embodiment of the present invention, in step a), the cells may further be subjected to cell recovery treatment and / or cell passage treatment.

[0067] Preferably, the cell recovery can be performed using methods known in the art, as long as the cells can be recovered, for example, according to the principle of rapid cell recovery. Exemplarily, the cell recovery specifically includes: re-dissolving the cells to be recovered in a 37°C water bath, centrifuging, resuspending the cells in a basal culture medium, and then culturing in an incubator (37°C, 5% CO2) for, for example, 48 hours.

[0068] Preferably, the cell passage can be performed using methods known in the art, as long as the desired cells can be obtained. For example, the culture medium is discarded from the revived cells, PBS is added to the culture wells and gently washed twice, followed by trypsin digestion to prepare a single-cell suspension, and the cells are resuspended in basal culture medium and adjusted to the desired cell density (e.g., 5K, 25K, 50K).

[0069] According to an embodiment of the present invention, the cells include human neuroblastoma cells, such as SH-SY5Y cells, and liver cancer cells, such as HepaRG.

[0070] According to an embodiment of the present invention, in step b), the culture can be performed by methods known in the art as long as the desired cells can be obtained, for example, adding the cell suspension to a culture plate and culturing at 37° C. and 5% CO 2 .

[0071] According to an embodiment of the present invention, in step b), the culturing time is 1 to 10 days, preferably 3 days.

[0072] According to an embodiment of the present invention, in step b), the culturing further comprises changing the medium, for example, changing the basal culture medium every 3 days.

[0073] The present invention also provides a kit comprising the above-mentioned 3D cell culture medium and instructions for use, wherein the culture medium comprises a cellulose-based hydrogel and a basal culture medium, and the matrix of the cellulose-based hydrogel is a cellulose copolymer, a cellulose derivative copolymer, or a blend thereof.

[0074] The present invention also provides a cellulose culture medium for tissue and organoid culture, wherein the cellulose culture medium comprises the above-mentioned cellulose-based hydrogel and a composite culture medium, and the matrix of the cellulose-based hydrogel is a cellulose copolymer, a cellulose derivative copolymer or a blend thereof.

[0075] According to an embodiment of the present invention, the composite culture medium further comprises a basal culture medium. According to an embodiment of the present invention, the basal culture medium can be selected from basal culture mediums known in the art. Exemplarily, the basal culture medium comprises DMEM / F12 (GIBCO / 10565018), 10% FBS (GIBCO / 10091-148), and 1% P / S (GIBCO / 15140122).

[0076] According to an embodiment of the present invention, the composite culture medium contains 100-500 ng / ml of epidermal growth factor (Epirregulin), for example, 200 ng / ml, 300 ng / ml, 400 ng / ml, 500 ng / ml.

[0077] According to an embodiment of the present invention, in every 100 mL of composite culture solution, the active components include at least:

[0078]

[0079] According to an exemplary embodiment of the present invention, the composite culture solution comprises:

[0080]

[0081]

[0082] The present invention also provides a method for preparing the above-mentioned cellulose culture medium for tissue and organoid culture, the preparation method comprising the following steps:

[0083] S1: preparing the above-mentioned cellulose-based hydrogel;

[0084] S2: mixing the cellulose-based hydrogel in step S1 with the composite culture solution to prepare the cellulose-based culture solution.

[0085] According to an embodiment of the present invention, in step S2, the volume ratio of the cellulose-based hydrogel to the composite culture solution is 1-10:1-10, for example, 1:1.

[0086] The present invention also provides use of a cellulose-based culture medium for tissue and organoid culture in culturing tissue or organoid.

[0087] The present invention also provides a method for culturing tissues or organoids, wherein the culturing method is carried out in the above-mentioned cellulose-based culture medium for culturing tissues and organoids.

[0088] According to an embodiment of the present invention, the tissue is preferably human gastric cancer tissue / normal gastric tissue or human intestinal cancer tissue / normal intestinal tissue.

[0089] According to an embodiment of the present invention, the culture method comprises the following steps:

[0090] a) Preparing a cell suspension of tissue or organoid: uniformly mixing a cellulose-based culture medium for tissue and organoid culture with cells of the tissue or organoid to obtain a cell suspension;

[0091] b) 3D culture: The cell suspension from step a) is cultured in an incubator.

[0092] According to an embodiment of the present invention, in step a), the cells of the tissue or organoid can be prepared by methods known in the art, which are not specifically limited in the present invention.

[0093] According to an embodiment of the present invention, in step b), the culture can be performed by methods known in the art as long as the desired cells can be obtained, for example, adding the cell suspension to a culture plate and culturing at 37° C. and 5% CO 2 .

[0094] According to an embodiment of the present invention, in step b), the culturing time is 1 to 10 days, preferably 3 days.

[0095] According to an embodiment of the present invention, in step b), the culturing further comprises changing the medium, for example, changing the basal culture medium every 3 days.

[0096] The present invention also provides a kit comprising a cellulose-based hydrogel and a composite culture medium and / or instructions for use. The matrix of the cellulose-based hydrogel is a cellulose copolymer, a cellulose derivative copolymer or a blend thereof, which is preferably used for the culture of organoids, and further preferably for the culture of gastric cancer organoids and intestinal cancer organoids.

[0097] The present invention also provides a cellulose-based culture medium for culturing stem cells, wherein the cellulose-based culture medium comprises the above-mentioned cellulose-based hydrogel and a base culture medium, and the matrix of the cellulose-based hydrogel is a cellulose copolymer, a cellulose derivative copolymer or a blend thereof.

[0098] According to an embodiment of the present invention, the basal culture medium can be selected from basal culture medium known in the art. For example, the basal culture medium includes DMEM / F12, mTeSR TM 1.

[0099] The present invention also provides a method for preparing the above-mentioned cellulose culture medium for culturing stem cells, the preparation method comprising the following steps:

[0100] S1: preparing a cellulose-based hydrogel formed by a cellulose copolymer, a cellulose derivative copolymer or a blend thereof;

[0101] S2: The cellulose-based hydrogel in step S1 is mixed with the basic culture solution to prepare the cellulose culture solution.

[0102] According to an embodiment of the present invention, in step S2, the volume ratio of the cellulose-based hydrogel to the basic culture medium is 1-10:1-10, for example, 1:1.

[0103] The present invention also provides a use of the above-mentioned cellulose-based culture medium in stem cell culture and induced differentiation organoid culture.

[0104] The present invention also provides a method for using the above-mentioned cellulose culture medium for stem cell culture and induced differentiation organoid culture.

[0105] According to an embodiment of the present invention, the stem cells are preferably adult stem cells or embryonic stem cells (ESCs) from mammals and primates; further preferably, they are pluripotent stem cells or multipotent stem cells, such as induced pluripotent stem cells (iPSCs), hematopoietic stem cells, neural stem cells, skin stem cells, mesenchymal stem cells, adipose stem cells, osteoblastic stem cells, cartilage stem cells, muscle stem cells, liver stem cells, pancreatic stem cells, endothelial stem cells, corneal stem cells, hair follicle stem cells, gastrointestinal stem cells, mammary stem cells, cardiac stem cells, etc.

[0106] According to an embodiment of the present invention, the stem cell culture method comprises the following steps:

[0107] a) pre-treating the stem cells before passage, diluting a cellulose-based hydrogel formed by a cellulose copolymer, a cellulose derivative copolymer, or a blend thereof, and placing the hydrogel in an incubator;

[0108] b) Digestion of the extracellular matrix: using Dispase to digest the extracellular matrix;

[0109] c) Add mTeSR TM 1. Puff the stem cells until they fall off and break into pieces;

[0110] d) The stem cell fragments are added to a culture dish containing a cellulose-based hydrogel for culture.

[0111] According to an embodiment of the present invention, in step a), the cellulose-based hydrogel is diluted with DMEM / F12, added to a culture plate after dilution, and allowed to stand at 37° C. for at least 1 hour.

[0112] According to an embodiment of the present invention, in step b), the digestion using Dispase can be performed using methods known in the art, for example, covering the well plate with Dispase and placing it in a 37° C. incubator until the edges of the stem cells begin to lift.

[0113] According to an embodiment of the present invention, step b) further comprises the steps of aspirating Dispase and washing with DPBS.

[0114] According to an embodiment of the present invention, in step c), the fragments are 1-2 mm.

[0115] According to an embodiment of the present invention, in step d), a method known in the art can be used for culturing, for example, using mTeSR TM 1. Replenish the culture medium, culture at 37°C, 5% CO2, and change the medium.

[0116] The present invention also provides a stem cell induced differentiation organoid culture medium, which includes a cellulose-based hydrogel formed by the cellulose copolymer, cellulose derivative copolymer or a blend thereof of the present invention, a definitive endoderm differentiation culture medium, a MH differentiation culture medium, and an organoid growth culture medium.

[0117] According to an embodiment of the present invention, the definitive endoderm differentiation culture medium comprises the following components:

[0118] RPMI1640, containing L-glutamine, penicillin-streptomycin, and Activin A.

[0119] According to an embodiment of the present invention, the definitive endoderm differentiation culture medium preferably comprises the following components:

[0120] RPMI1640, containing L-glutamine 2mM, penicillin-streptomycin 100U / ml-100g / ml, and Activin A 100ng / ml.

[0121] According to an embodiment of the present invention, the MH differentiation culture medium comprises the following components:

[0122] RPMI1640 contains 2% FBS, L-glutamine, penicillin-streptomycin, and FGF4.

[0123] According to an embodiment of the present invention, the MH differentiation culture medium preferably comprises the following components:

[0124] RPMI1640 contains 2% FBS, L-glutamine, 2 mM, penicillin-streptomycin, 100 U / ml-100 g / ml, and FGF 4500 ng / ml.

[0125] According to an embodiment of the present invention, the organoid growth culture medium includes the following components:

[0126] Advanced DMEM / F12 with 1× B27, L-glutamine, penicillin-streptomycin, HEPES buffer, and R-spondin 1.

[0127] According to an embodiment of the present invention, the organoid growth culture medium preferably comprises the following components:

[0128] Advanced DMEM / F12 contains 1×B27, L-glutamine, 2 mM, penicillin-streptomycin, 100 U / ml-100 μg / ml, HEPES buffer, 15 mM, and R-spondin 1, 500 ng / ml.

[0129] The present invention also provides a use of the above-mentioned stem cell-induced differentiation organoid culture medium in stem cell-induced differentiation organoids.

[0130] The present invention also provides a method for inducing stem cell differentiation into organoids, wherein the method comprises culturing a single stem cell or a stem cell population in a stem cell differentiation-inducing organoid culture medium.

[0131] According to an embodiment of the present invention, the method for inducing stem cell differentiation into organoids comprises the following steps:

[0132] a) iPSC / ES differentiation in monolayer culture, including definitive endoderm differentiation and mid / hindgut (MH) differentiation;

[0133] b) organoid culture, including preparation of an organoid growth culture medium, and mixing a cellulose-based hydrogel formed by a cellulose copolymer, a cellulose derivative copolymer, or a blend thereof with the spheroids and incubating the mixture.

[0134] According to an embodiment of the present invention, the definitive endoderm differentiation in step a) includes the preparation of a definitive endoderm differentiation culture medium and the definitive endoderm differentiation, wherein the definitive endoderm differentiation step includes incubating using the definitive endoderm differentiation culture medium using a method known in the art, such as incubation at 37°C, 5% CO2 and 95% humidity.

[0135] According to an embodiment of the present invention, the midgut / hindgut (MH) differentiation in step a) includes the preparation of MH differentiation culture medium and midgut / hindgut (MH) differentiation, wherein the midgut / hindgut (MH) differentiation step includes incubating with MH differentiation culture medium using methods known in the art, such as incubation at 37°C, 5% CO2 and 95% humidity, changing the medium and observing the spheres every 24 hours, and embedding the spheres.

[0136] According to an embodiment of the present invention, the cellulose-based hydrogel and the spheroids in step b) are mixed and incubated using methods known in the art, for example, including: incubating at 37°C for less than 30 minutes, adding organoid growth medium and continuing to incubate at 37°C, 5% CO2, and 95% humidity, and subculturing according to the growth of the organoids.

[0137] The present invention also provides a stem cell organoid obtained by the method of the present invention, such as an adult stem cell organoid, an induced pluripotent stem cell organoid or an embryonic stem cell organoid.

[0138] The present invention also provides an induced differentiation organoid kit, comprising a cellulose-based hydrogel formed by the cellulose copolymer, cellulose derivative copolymer or a blend thereof of the present invention. The induced differentiation organoid is preferably an intestinal organoid, a gastric organoid, a liver organoid, and more preferably a small intestinal organoid.

[0139] According to an embodiment of the present invention, the kit further comprises a definitive endoderm differentiation culture medium, a MH differentiation culture medium, and an organoid growth culture medium.

[0140] According to an embodiment of the present invention, the kit further includes components or assemblies known in the art, which are not specifically limited in the present invention.

[0141] Beneficial effects of the present invention:

[0142] The present invention uses cellulose derivatives as raw materials to prepare cellulose derivative-based hydrogels, which are ready-to-use hydrogels that do not contain animal-derived components. Specifically, the matrix of the hydrogel includes cellulose derivatives, and the matrix includes a network structure composed of ultrafine cellulose derivative fibers, and the network structure includes an ordered three-dimensional micro-nanostructure. Compared with animal-derived matrix glue, it has incomparable advantages in performance, ease of use, batch-to-batch stability, process amplification stability, and automation compatibility.

[0143] The cellulose-based hydrogels prepared from cellulose copolymers, cellulose derivative copolymers, or blends thereof exhibit enhanced transparency, facilitating better observation of cell status. They are suitable for 3D cell culture, such as SH-SY5Y and HepaRG cells, and for the culture of tissues and organoids, such as human gastric cancer tissue / normal gastric tissue, human intestinal cancer tissue / normal intestinal tissue, and preferably human gastric cancer organoids / normal gastric organoids, or human intestinal cancer organoids / normal intestinal organoids.

[0144] The cellulose copolymer, cellulose derivative copolymer, or their blends of the present invention are non-toxic to cells. Cellulose-based hydrogels prepared from the cellulose copolymer, cellulose derivative copolymer, or their blends serve as a stem cell growth platform and have good rigidity, adhesion, and porosity. Stem cells cultured in the cellulose-based hydrogels prepared from the cellulose copolymer, cellulose derivative copolymer, or their blends of the present invention can form clusters. Cellulose-based hydrogels prepared from the cellulose copolymer, cellulose derivative copolymer, or their blends of the present invention are simple to operate and form a dense, fused monolayer of endoderm cells. The non-directional differentiation of stem cells is inhibited, and the resulting organoid vesicles have thick, solid walls and are mature, differentiated organoids that can be used for high-throughput drug screening, drug toxicity testing, and regenerative medicine. BRIEF DESCRIPTION OF THE DRAWINGS

[0145] Figure 1a Scanning electron micrograph of cellulose ester grafted polylactic acid hydrogel.

[0146] Figure 1b Micrograph of cell suspension on cellulose ester-grafted polylactic acid hydrogel after 1 day of culture.

[0147] Figure 1c Micrograph of cell suspension on cellulose ester-grafted polylactic acid hydrogel after 3 days of culture.

[0148] Figure 1d Micrograph of cell suspension on cellulose ester-grafted polylactic acid hydrogel after 5 days of culture.

[0149] Figure 1e Micrograph of cell suspension on cellulose ester-grafted polylactic acid hydrogel after 7 days of culture.

[0150] Figure 2a Micrograph of SH-SY5Y cells cultured in 3D on cellulose ester-grafted polylactic acid hydrogel for 5 days.

[0151] Figure 2b Micrograph of SH-SY5Y cells cultured in 3D culture on GrowDex, a plant-based cellulose matrix, for 5 days.

[0152] Figure 3aMicrograph of HepaRG cells cultured on cellulose acetate-grafted polycaprolactone hydrogels after 7 days of 3D culture.

[0153] Figure 3b Micrograph of HepaRG cells cultured on cellulose propionate-grafted polyethylene carbonate hydrogels after 7 days of 3D culture.

[0154] Figure 3c Micrograph of HepaRG cells cultured on cellulose butyrate-grafted poly(propylene carbonate) hydrogels after 7 days of 3D culture.

[0155] Figure 3d Micrograph of HepaRG cells cultured on cellulose acetate-grafted polydioxanone hydrogels after 7 days of 3D culture.

[0156] Figure 3e Micrograph of HepaRG cells cultured on cellulose ester-grafted polylactic acid hydrogel (cellulose concentration 0.2%) after 7 days of 3D culture.

[0157] Figure 1a-1 Gastric cancer organoids were cultured on cellulose ester-grafted polylactic acid hydrogel (cellulose concentration was 0.2%) for one day.

[0158] Figure 1b-1 Gastric cancer organoids were cultured on cellulose ester-grafted polylactic acid hydrogel (cellulose concentration was 0.2%) for 3 days.

[0159] Figure 1c-1 Gastric cancer organoids were cultured on cellulose ester-grafted polylactic acid hydrogel (cellulose concentration was 0.2%) for 7 days.

[0160] Figure 2a-1 Micrograph of gastric cancer organoids cultured on cellulose ester-grafted polylactic acid hydrogel (cellulose concentration 0.3%) for 7 days.

[0161] Figure 2b-1 Micrograph of gastric cancer organoids cultured in Matrigel for 7 days.

[0162] Figure 2c-1 Micrograph of gastric cancer organoids cultured on GrowDex for 7 days.

[0163] Figure 3a-1 Micrograph of gastric cancer organoids cultured on cellulose acetate-grafted polycaprolactone hydrogel for 7 days.

[0164] Figure 3b-1 Micrograph of gastric cancer organoids cultured on cellulose propionate-grafted polyethylene carbonate hydrogel for 7 days.

[0165] Figure 3c-1 Micrograph of gastric cancer organoids cultured on cellulose butyrate-grafted poly(propylene carbonate) hydrogel for 7 days.

[0166] Figure 3d-1 Microscopic image of gastric cancer organoids cultured on cellulose acetate-grafted polydioxanone hydrogels after 7 days.

[0167] Figure 4a-1 Microscopic image of colorectal cancer organoids cultured on cellulose ester-grafted polylactic acid hydrogel after 7 days.

[0168] Figure 4b-1 Microscopic image of colorectal cancer organoids cultured on cellulose acetate-grafted polycaprolactone hydrogel for 7 days.

[0169] Figure 4c-1 Microscopic image of colorectal cancer organoids cultured on cellulose propionate-grafted polyethylene carbonate hydrogel for 7 days.

[0170] Figure 4d-1 Microscopic image of colorectal cancer organoids cultured on cellulose butyrate-grafted poly(propylene carbonate) hydrogel for 7 days.

[0171] Figure 4e-1 Microscopic image of colorectal cancer organoids cultured on cellulose acetate-grafted polydioxanone hydrogel for 7 days.

[0172] Figure 1a-2 Micrograph of intestinal organoids 3 days after induction of differentiation of human pluripotent stem cells / embryonic stem cells in Example 2-2.

[0173] Figure 1b-2 Micrograph of intestinal organoids 7 days after induction of differentiation of human pluripotent stem cells / embryonic stem cells in Example 2-2.

[0174] Figure 1c-2 Micrograph of intestinal organoids 12 days after induction of differentiation of human pluripotent stem cells / embryonic stem cells in Example 2-2.

[0175] Figure 2a-2 Micrograph of iPSCs cultured on 0.8% cellulose ester grafted polylactic acid hydrogel in Comparative Example 1-2.

[0176] Figure 2b-2 Micrograph of iPSCs cultured on Matrigel (Corning 354277) in Comparative Example 1-2.

[0177] Figure 3a-2 Micrograph of intestinal organoids induced and differentiated by human pluripotent stem cells / embryonic stem cells after 12 days of culture using the inducing differentiation intestinal organoid kit containing 0.3% cellulose ester grafted polylactic acid hydrogel in Comparative Example 2-2.

[0178] Figure 3b-2 STEMdiff in Comparative Example 2-2 TMMicrograph of intestinal organoids 12 days after induction of differentiation of human pluripotent stem cells / embryonic stem cells using the Intestinal Organoid Kit (stem cell, 05140).

[0179] Figure 4a-2 Micrograph of intestinal organoids (12 days) cultured on cellulose acetate-grafted polycaprolactone hydrogel.

[0180] Figure 4b-2 Micrograph of intestinal organoids (12 days) cultured on cellulose propionate-grafted polyethylene carbonate hydrogel.

[0181] Figure 4c-2 Micrograph of intestinal organoids (12 days) cultured on cellulose butyrate-grafted poly(propylene carbonate) hydrogel.

[0182] Figure 4d-2 Micrograph of intestinal organoids (12 days) cultured on cellulose acetate-grafted polydioxanone hydrogel. DETAILED DESCRIPTION

[0183] The technical solutions of the present invention will be described in further detail below with reference to specific embodiments. It should be understood that the following embodiments are merely illustrative and explanations of the present invention and should not be construed as limiting the scope of protection of the present invention. All technologies implemented based on the above content of the present invention are encompassed within the scope of protection that the present invention is intended to protect.

[0184] Unless otherwise specified, the raw materials and reagents used in the following examples are commercially available or can be prepared by known methods.

[0185] The present invention will be further described below by means of specific embodiments:

[0186] Preparation Example 1: Preparation of cellulose derivative copolymer-based hydrogel

[0187] (1) Preparation of cellulose ester grafted polylactic acid hydrogel

[0188] 15g of cellulose is added to 300g of the ionic liquid 1-allyl-3-methylimidazolium chloride (AmimCl) and mechanically stirred at 80°C for 2h to dissolve the cellulose. The cellulose can be microcrystalline cellulose, refined cotton, cotton pulp, or wood pulp. A certain amount of anhydride (at a 1:1 molar ratio with the cellulose) is then added. The anhydride can be acetic anhydride, propionic anhydride, butyric anhydride, or maleic anhydride, and the mixture is allowed to react at 80°C for 2h. Next, 11.3g of DMAP (at a 1:1 molar ratio with the cellulose) and 80g of lactide (at a 2:1 molar ratio with the hydroxyl groups in the cellulose) are added. The mixture is allowed to react at 80°C for 5h under vacuum. After the reaction is complete, the reaction solution is poured into water and stirred to precipitate the product. The product is then filtered and washed 6-8 times with a solution such as water, ethanol, acetone, or ethylene glycol to remove any remaining impurities. The washed product was dispersed in pure water with a mass ratio of water to product of 9:1, and then the product was crushed and crushed to a particle size of 1-50 μm and a solid content of 0.1-3.0 wt% using a colloid mill or a high-pressure homogenizer. After high-pressure sterilization, a cellulose ester grafted polylactic acid hydrogel was obtained (see Figure 1a ).

[0189] (2) Preparation of Cellulose Acetate Grafted Polycaprolactone Hydrogel

[0190] 6 g of wood pulp cellulose is added to 120 g of ionic liquid 1-allyl-3-methylimidazolium chloride (AmimCl), and the mixture is mechanically stirred at 80°C for 2 hours to dissolve the cellulose. Then, 14 ml of acetic anhydride (at a molar ratio of 4:3 to the hydroxyl groups in the cellulose) is added, and the reaction is continued at 40°C with stirring for 1 hour. Then, 2.06 g of PPY (at a molar ratio of 1:8 to the hydroxyl groups in the cellulose) and 12.7 g of ε-caprolactone (at a molar ratio of 1:1 to the hydroxyl groups in the cellulose) are added, and the temperature is raised to 90°C. The grafting reaction is carried out under nitrogen protection for 4 hours. After the reaction is completed, the reaction solution is poured into water, stirred to precipitate the product, filtered, and the product is washed 6-8 times with a solution to remove residual impurities. The solution that can be used includes water, ethanol, acetone, and ethylene glycol. The washed product is dispersed in pure water with a mass ratio of water to product of 9:1. The product is then crushed and pulverized using a colloid mill, a high-pressure homogenizer, or the like to a particle size of 1-50 μm and a solid content of 0.1-3.0 wt%. After high-pressure sterilization, a cellulose acetate grafted polycaprolactone hydrogel is obtained.

[0191] (3) Preparation of Cellulose Propionate Grafted Polyethylene Carbonate Hydrogel

[0192] 24g of cotton pulp was added to 300g of ionic liquid BMIMCl and mechanically stirred at 80°C for 3h to dissolve the cellulose. 38.2ml of propionic anhydride (at a molar ratio of 2:3 to the hydroxyl groups in the cellulose) was then added and the mixture was allowed to react at 80°C for 2h. 18.1g of DMAP (at a molar ratio of 1:3 to the hydroxyl groups in the cellulose) and 117.4g of ethylene carbonate (at a molar ratio of 3:1 to the hydroxyl groups in the cellulose) were then added and the mixture was allowed to react at 80°C for 9h under vacuum. After the reaction, the reaction mixture was poured into water, stirred to precipitate the product, filtered, and washed 6-8 times with a solution such as water, ethanol, acetone, or ethylene glycol to remove any remaining impurities. The washed product was dispersed in pure water at a water:product mass ratio of 9:1. The product was then pulverized and ground using a colloid mill, high-pressure homogenizer, or the like to a particle size of 1-50μm and a solids content of 0.1-3.0wt%. The product was then sterilized by autoclave to obtain a cellulose propionate-grafted polyethylene carbonate hydrogel.

[0193] (4) Preparation of Cellulose Butyrate Grafted Polypropylene Carbonate Hydrogel

[0194] 9 g of cotton pulp was added to 200 g of ionic liquid AMIMCl and mechanically stirred at 80° C. for 3 h to dissolve the cellulose. 45 ml of butyric anhydride (at a molar ratio of 5:3 to the hydroxyl groups in the cellulose) was then added and stirred at 90° C. for 3 h. 6.75 g of stannous octoate (at a molar ratio of 1:10 to the hydroxyl groups in the cellulose) and 34.0 g of propylene carbonate (at a molar ratio of 2:1 to the hydroxyl groups in the cellulose) were then added and the grafting reaction was carried out at 120° C. under nitrogen atmosphere for 10 h. The product was precipitated with water, filtered, and washed 6-8 times with a solution such as water, ethanol, acetone, or ethylene glycol to remove residual impurities. The washed product was dispersed in pure water at a water-to-product mass ratio of 9:1. The product was then crushed and pulverized using a colloid mill, a high-pressure homogenizer, or the like to a particle size of 1-50 μm and a solid content of 0.1-3.0 wt%. After autoclaving, a cellulose butyrate grafted polypropylene carbonate hydrogel was obtained.

[0195] (5) Preparation of Cellulose Acetate Grafted Polydioxanone Hydrogel

[0196] 5g of cotton pulp was added to 100g of the ionic liquid EMIMAc and mechanically stirred at 80°C for 3h to dissolve the cellulose. The mixture was then cooled to 40°C and 8.8ml of acetic anhydride (at a 1:1 molar ratio of hydroxyl groups in the cellulose) was added. The mixture was stirred for 0.5h. 1.41g of DMAP (at a 1:8 molar ratio of hydroxyl groups in the cellulose) and 18.9g of dioxanone (at a 2:1 molar ratio of hydroxyl groups in the cellulose) were then added. The mixture was heated to 85°C and nitrogen was introduced for grafting reaction for 4h. The product was precipitated with water, filtered, and washed 6-8 times with a solution (e.g., water, ethanol, acetone, or ethylene glycol) to remove residual impurities. The washed product was dispersed in pure water at a water:product mass ratio of 9:1. The product was then pulverized and ground using a colloid mill, high-pressure homogenizer, or the like to a particle size of 1-50μm and a solid content of 0.1-3.0wt%. After autoclaving, the cellulose acetate grafted polydioxanone hydrogel was obtained.

[0197] Part I: 3D cell culture based on cellulose-based hydrogels formed from cellulose copolymers, cellulose derivative copolymers, or blends thereof

[0198] Example 1

[0199] The cell culture method is as follows:

[0200] 1) Cell Passaging: Commercially available SH-SY5Y cells were selected and revived, cultured in 10 cm culture dishes, and passaged when a confluency of 80% or greater was achieved. The original culture medium in the culture dish was discarded, and the dish was gently washed twice with PBS. A single-cell suspension was then prepared using trypsinization and centrifuged at 1200 rpm for 5 min at room temperature. The cells were resuspended in basal culture medium (composed of: DMEM / F12, 10% FBS, 1% P / S; this basal culture medium was used in all following examples unless otherwise specified) and adjusted to the desired cell density of 2 × 10^4 cells / μL. This provided SH-SY5Y cells for experimental use and set aside.

[0201] 2) Preparing a cellulose ester grafted polylactic acid culture solution: taking the cellulose ester grafted polylactic acid hydrogel prepared in the above Preparation Example 1, and diluting it with the basic culture solution in step 1) to obtain a cellulose ester grafted polylactic acid culture solution with a cellulose ester grafted polylactic acid concentration of 0.2%.

[0202] 3) Cell suspension mixing: 500 μL of the cellulose ester grafted polylactic acid culture medium from step 2) was mixed with 500 μL of the basal culture medium at a volume ratio of 1:1, and 10 μL of the experimental SH-SY5Y cells from step 1) was added and mixed evenly to obtain a cell suspension.

[0203] 4) 3D culture: 1 mL of the cell suspension mixed in step 3) was added to a 12-well culture plate and cultured in a 37° C., 5 vol% CO 2 incubator.

[0204] 5) Medium exchange: The culture medium was changed after 3 days of culture, and the culture medium was changed every 3 days. Specifically, the culture plate containing cells in step 4) was centrifuged at 1200 rpm at room temperature for 5 minutes, the culture medium in the upper layer of the culture plate was discarded, and new basal culture medium was added.

[0205] The micrographs of the cell suspension after culturing for 1 day, 3 days, 5 days and 7 days are shown in Figure 2. Figure 1b to Figure 1e shown.

[0206] Comparative Example 1

[0207] The cellulose ester grafted polylactic acid hydrogel of the present invention and the plant cellulose matrix glue GrowDex (UPM / 100103005) were used to culture SH-SY5Y cells in 3D for 5 days. The results are shown in FIG. Figure 2a 、 2b .

[0208] Example 2

[0209] The operation was the same as in Example 1, except that the cultured cells were different (HepaRG (liver cancer cells)). The hydrogels were: cellulose acetate grafted polycaprolactone hydrogel, cellulose propionate grafted polyethylene carbonate hydrogel, cellulose butyrate grafted polypropylene carbonate hydrogel, cellulose acetate grafted polydioxanone hydrogel, and cellulose ester grafted polylactic acid hydrogel. Figure 3a to Figure 3e These are micrographs of HepaRG cells (7 days) cultured in the above hydrogel 3D.

[0210] Part II: Tissue and Organoid Culture

[0211] The types of raw materials involved in the following examples are as follows:

[0212] P / S Penicillin-Streptomycin, GIBCO / 15140122;

[0213] HEPESN-2-hydroxyethylpiperazine-N-2-ethanesulfonic acid, GIBCO / 15630080;

[0214] L-glutamine supplement Glutamax, GIBCO / 35050061;

[0215] Neuronal Cell Culture Supplement B27, GIBCO / 17504044;

[0216] N-Acetylcysteine, Sigma / A9165-100G;

[0217] Fibroblast growth factor 7FGF-7, mce / HY-P7047A;

[0218] Noggin, mce / HY-P70558;

[0219] R-spondin 1, PeproTech / 120-38;

[0220] WNT protein Wnt 3A, PeproTech / 315-20;

[0221] Human fibroblast growth factor 10FGF10, PeproTech / 100-26;

[0222] Gastrin, mce / HY-P1097;

[0223] ALK inhibitors A-83-01, mce / HY-10432;

[0224] ROCK inhibitor Y-27632, mce / HY-10071;

[0225] p38 MAPK inhibitor SB202190, mce / HY-10295;

[0226] Epirregulin, mce / HY-P7011;

[0227] Carotenoid Capsanthin, mce / HY-125711;

[0228] Nicotinamide, Sigma / N0636.

[0229] Example 1-1

[0230] 1. The formula of the composite culture solution is as follows: the composite culture solution is obtained by mixing the following components:

[0231] Serial number Components Mass concentration 1 Ad DMEM / F12 97% 2 P / S 1% 3 HEPES 10mM 4 Glutamax 1% 5 B27 1% 6 N-Acetylcysteine 1.25mM 7 FGF-7 50ng / ml 8 Noggin 100ng / ml 9 R-spondin 1 500ng / ml 10 Wnt 3A 100ng / ml 11 FGF10 200ng / ml 12 Gastrin 1nM 13 A-83-01 2μM 14 Y-27632 10 μM 15 SB202190 10 μM 16 Epirregulin 200ng / ml 17 Capsanthin 200ng / ml 18 Nicotinamide 10mM

[0232] 2. Prepare the tissue to be cultured

[0233] (1) Tissue cleaning

[0234] Transfer the tissue block (e.g., gastric cancer organoids, hospital surgical tissue, or biopsy tissue) to a 50 ml centrifuge tube, add 15 ml of washing solution (PBS + 2×P / S), and shake and wash for at least 5 times, each time for 6 minutes, until completely clear.

[0235] (2) Tissue separation

[0236] Transfer the tissue block to a 10 cm culture dish, add a small amount of cleaning solution to ensure the tissue surface is moistened, and use a sterile scalpel and blade to mechanically separate the tissue until it becomes small fragments or a paste of approximately 0.5×0.5×0.5 mm^3.

[0237] (3) Tissue digestion

[0238] The mechanically separated tissue was completely transferred into a 15 ml sterile centrifuge tube. Depending on the amount of tissue, 2-5 ml of tissue digestion solution (collagenase P (1 mg / ml) + DNase (1 mg / ml)) was added. The tissue was gently pipetted with a 1 ml pipette tip to fully disperse it. The centrifuge tube containing the digestion solution was placed on a shaker in a constant temperature air bath at 37°C and 200 rpm. After most of the tissue was separated and digested into 3-10 cell clusters, 10% FBS was added to terminate the digestion.

[0239] (4) Cell filtration

[0240] Filter the cell suspension after the termination of digestion through a 100 μm filter into a new 50 ml centrifuge tube. Use a 5 ml syringe pump to grind the sample pellet until the digested tissue sample is ground into only white connective tissue. Wash the filter three times with DMEM / F12, approximately 5 ml each time.

[0241] Centrifuge at 4°C, 300g / 1260rpm for 5 min.

[0242] (5) Lysis of red blood cells

[0243] If a large number of red blood cells are observed in the cell pellet, perform the following red blood cell lysis step:

[0244] Remove the supernatant and resuspend the cell pellet in 1 ml of red blood cell lysis buffer. Mix thoroughly by pipetting. Place the tube on a shaker at 120 rpm at 4°C for 5 minutes. Centrifuge at 300g / 1260 rpm at 4°C for 5 minutes. Resuspend the cell pellet in 10 ml of Advanced DMEM / F12 and transfer the suspension to a 15 ml centrifuge tube. Centrifuge at 300g / 1260 rpm at 4°C for 5 minutes.

[0245] (6) Cell seeding plate

[0246] Discard the supernatant and retain an appropriate volume (depending on the number of cells, 100,000 cells / well is recommended) of liquid, which is the tissue cell liquid to be cultured.

[0247] 3. Preparation of cellulose ester grafted polylactic acid culture medium:

[0248] The cellulose ester grafted polylactic acid hydrogel prepared in Example 1 was diluted with the composite culture solution, wherein the concentration of the cellulose ester grafted polylactic acid was 0.1-0.8%, to obtain a cellulose ester grafted polylactic acid culture solution.

[0249] 4. 3D Culture: Gently resuspend the tissue cell suspension from step 2 and the cellulose ester-grafted polylactic acid culture medium from step 3 above. Add 300 μl per well of a preheated 24-well low-adhesion cell culture plate. Place the plate in a 37°C, 5% CO2 incubator and heat for 10 minutes. Remove the plate and add 700 μl / well of the preheated combined culture medium. Incubate the plate in a 37°C, 5% CO2 incubator until passage.

[0250] Example 2-1

[0251] This example is basically the same as Example 1-1, except that: the cellulose ester grafted polylactic acid hydrogel prepared in Example 1 was diluted with a composite culture medium to obtain a cellulose-based hydrogel with a cellulose concentration of 0.2%. Gastric cancer organoids were cultured. The culture results are shown in FIG. Figure 1a-1 to Figure 1c-1 .

[0252] from Figure 1a-1 to Figure 1c-1 It can be seen that after different days of culture, obvious 3D cell spheres can be observed on the first day of culture; when growth continues to the third day, the diameter of these cell spheres increases significantly and the cell walls thicken; when growth reaches the seventh day, the maximum diameter can reach 200μm, showing the typical differentiated and mature 0-day gastric cancer organoid morphology.

[0253] Comparative Example 1-1

[0254] This example is basically the same as Example 1-1, except that: the cellulose ester grafted polylactic acid hydrogel prepared in Preparation Example 1 was diluted with a composite culture medium to obtain MC with a cellulose concentration of 0.3%, Matrigel (Corning / 356231), and plant cellulose matrix gel GrowDex (UPM / 100103005). Referring to step 4 of Example 1-1, the tissue cell fluid to be cultured, i.e., gastric cancer organoids, was cultured separately. The culture results are shown in FIG. Figure 2a-1 、 2b-1 、2c-1.

[0255] After 7 days of culture, compared with cellulose ester grafted polylactic acid hydrogel, Matrigel, and GrowDex, the gastric cancer organoids in the cellulose ester grafted polylactic acid hydrogel group had uniform morphology and size, thicker cell walls, and showed the typical morphology of differentiated and mature gastric cancer organoids, which was superior to the other two groups.

[0256] Example 3-1

[0257] The operation was the same as that of Examples 1-1 and 2-1, but different hydrogels were used. The matrix gels were cellulose acetate grafted polycaprolactone hydrogel, cellulose propionate grafted polyethylene carbonate hydrogel, cellulose butyrate grafted polypropylene carbonate hydrogel, and cellulose acetate grafted polydioxanone hydrogel. Figures 3a-3d These are micrographs of gastric cancer organoids cultured in the above hydrogels (7 days).

[0258] Example 4-1

[0259] The basic examples 1-1 and 2-1 were operated, but the cultured tissues were different, namely, colorectal cancer organoids, and the hydrogels were: cellulose ester grafted polylactic acid hydrogel, cellulose acetate grafted polycaprolactone hydrogel, cellulose propionate grafted polyethylene carbonate hydrogel, cellulose butyrate grafted polypropylene carbonate hydrogel, and cellulose acetate grafted polydioxanone hydrogel. Figure 4a-1 to Figure 4e-1 These are microscopic images of intestinal cancer organoids cultured in the above hydrogels after 7 days.

[0260] Part III: Stem Cell Culture and Induced Differentiation of Organoids

[0261] Example 1-2 Human induced pluripotent stem cell / embryonic stem cell culture

[0262] 1) Before passaging stem cells, dilute the cellulose ester grafted polylactic acid hydrogel to 0.8% in DMEM / F12, add 1 ml / well to a 6-well plate, and place in a 37°C incubator for at least 1 hour.

[0263] 2) Stem cell passage: The cells in the culture dish are about 85-90% confluent and have basically not differentiated. TM After aspirating 1 (STEMCELL, 85850), each well was covered with 1 ml of Dispase (1 mg / ml) and placed in a 37°C incubator until the edge of the stem cells began to lift, and the Dispase was aspirated.

[0264] 3) Wash three times with DPBS, 1 ml each time.

[0265] 4) Add 3 ml of preheated mTeSR TM 1. Add the cells to the wells and gently pipette until the stem cells fall off the well plate. Repeat the pipetting until the cell clusters are broken down into 1-2 mm fragments.

[0266] 5) The stem cell fragments were added to the well plate covered with cellulose ester grafted polylactic acid hydrogel in a ratio of 1:1 to 1:6, and the mTeSR TM1. Fill the volume to 2 ml with culture medium (STEMCELL, 85850). Gently tap the side of the 6-well culture dish 5 to 10 times to ensure that the stem cell colonies are evenly distributed in the air. Incubate the culture in a 37°C, 5% CO2 incubator, changing the medium daily.

[0267] Example 2-2 Human pluripotent stem cells / embryonic stem cells induced differentiation of intestinal organoids

[0268] 1. iPSC / ES cell differentiation in monolayer culture

[0269] To perform differentiation in a TC-treated 24-well cell culture plate, dilute the cellulose ester-grafted polylactic acid hydrogel to 0.8% in DMEM / F12, add 0.3 ml / well to the 24-well plate, and incubate in a 37°C incubator for at least 1 hour. Before initiating differentiation, assess the cell differentiation rate and starting density. At this point, the cell differentiation rate should be less than 5% and the starting density should be 85-90%.

[0270] (1) Definitive endoderm differentiation

[0271] A. Preparation of Definitive Endoderm Differentiation Medium

[0272] Day 0: Prepare 0.5 mL of definitive endoderm differentiation medium (RPMI 1640, containing L-glutamine (final concentration 2 mM), penicillin-streptomycin (final concentration 100 U / ml-100 g / ml), and Activin A (final concentration 100 ng / ml)) required for days 0, 1, and 2 for each culture well.

[0273] B. Definitive endoderm differentiation

[0274] 1) Day 0: Preheat the definitive endoderm differentiation medium (0.5 mL / well) required for day 0 at 37°C. Store the remaining medium at 2-8°C. Aspirate the mTeSR in the culture wells. TM 1. Add 0.5 mL of Definitive Endoderm Differentiation Medium dropwise along the well wall. Incubate at 37°C, 5% CO2, and 95% humidity for 24 hours.

[0275] 2) Day 1: Preheat the definitive endoderm differentiation medium (0.5 mL / well) at 37°C. Aspirate the medium from the wells and add 0.5 mL of the medium dropwise along the well walls. Incubate at 37°C, 5% CO2, and 95% humidity for 24 hours.

[0276] 3) Day 2: Aspirate the culture medium from the culture wells and add 0.5 mL of 37°C preheated definitive endoderm differentiation medium dropwise along the well walls.

[0277] Incubate at 37°C, 5% CO2 and 95% humidity for 24 hours.

[0278] Note: During endoderm induction, cells undergo extensive cell death. Minimize the time cells spend outside the 37°C incubator. Within 24 hours of endoderm induction, cells are very sensitive and require careful medium changes during culture. After 72 hours of incubation, a dense, confluent monolayer of endoderm cells will form.

[0279] (2) Midgut / hindgut (MH) differentiation

[0280] A.MH differentiation medium

[0281] Day 3: Prepare MH differentiation medium (RPMI1640 containing 2% FBS, L-glutamine (final concentration 2 mM), penicillin-streptomycin (final concentration 100 U / ml-100 g / ml), FGF4 (final concentration 500 ng / ml) required for days 3-8, 0.5 mL per culture well.

[0282] B. Midgut / Hindgut (MH) Differentiation

[0283] Day 3: Warm an adequate volume of MH Differentiation Medium (0.5 mL / well) to room temperature (15–25°C). Aspirate the medium from the wells and add 0.5 mL of Midgut / Hindgut Differentiation Medium dropwise along the well walls. Incubate at 37°C, 5% CO2, and 95% humidity for 24 hours.

[0284] 2) Days 4-9: Replace all the medium and observe the spheroids every 24 hours according to the following method.

[0285] NOTE: Ensure that cultures are returned to the incubator within 30 minutes of removal.

[0286] a. Observe the monolayer under a microscope. Three-dimensional structures may appear as early as day 4 of differentiation. Free-floating mid / hindgut spheroids will appear between days 6-9 of differentiation.

[0287] b. Using a 1 mL pipette, remove 0.5 mL of culture medium from the cells and transfer to a sterile 24-well flat-bottom clear culture plate to assess the number and concentration of mid / hindgut spheroids extracted from the monolayer.

[0288] c. Add 0.5 mL of fresh MH medium to the cells and incubate at 37°C, 5% CO2, and 95% humidity for 24 hours.

[0289] Note: Although spheres released from days 6-9 can generate intestinal organoids, the length of time cells are cultured in mid / hindgut culture will determine the regional characteristics of the intestinal organoid development. For example, the duodenum (shorter culture time) or ileum (longer culture time). The time at which the highest yield of mid / hindgut spheres occurs may vary between hPSC cell lines. For reproducible experimental results, use mid / hindgut spheres differentiated at the same time point to consistently harvest and initiate human intestinal organoid culture.

[0290] 3) Spheroid Embedding: Use a pipette rinsed with 0.5% BSA to add the spheroid suspension from each well to one well of a 24-well plate for counting. Add an appropriate volume to a 15 mL centrifuge tube, corresponding to approximately 50 suspended spheres (based on the previous spheroid count).

[0291] A mid / hindgut spheroid is a cell aggregate ≥75 μm in diameter that can potentially form a human intestinal organoid. Multiple fused spheroids should be counted as one unit and will form a human intestinal organoid.

[0292] The remaining monolayer culture can be used to assay mid / hindgut formation or to study further differentiation into chimeric spheroids in subsequent days.

[0293] 2. Human intestinal organoid culture

[0294] (1) Initial culture of human intestinal organoids

[0295] A. Preparation of Intestinal Organoid Growth Medium

[0296] 1) Culture in a 24-well low-adhesion culture plate. Prepare 4 wells (0.5 mL / well) of intestinal organoid growth medium (Advanced DMEM / F12 supplemented with 1× B27, L-glutamine (final concentration 2 mM), penicillin-streptomycin (final concentration 100 U / ml-100 μg / ml), HEPES buffer (final concentration 15 mM), and R-spondin 1 (final concentration 500 ng / ml).

[0297] B. Cellulose ester grafted polylactic acid hydrogel mixed with spheres

[0298] 1) Centrifuge the spheroid suspension collected during midgut / hindgut (MH) differentiation described in step B at 300×g for 5 minutes. Carefully aspirate the supernatant after centrifugation.

[0299] 2) Add 1 mL of DMEM / F-12 + 15 mM HEPES to the spheroids. Centrifuge at 300 × g for 5 minutes at room temperature (15-25°C).

[0300] 3) Carefully remove the supernatant using a 1 mL pipette tip.

[0301] 5) Add 100 μL of 0.3% cellulose ester grafted polylactic acid hydrogel to the centrifuge tube. Pipet up and down 5 times to gently distribute the spheres into the cellulose ester grafted polylactic acid hydrogel.

[0302] NOTE: Do not completely empty the pipette tip to prevent excessive air bubbles.

[0303] 6) Using the same pipette tip, gently transfer the embedded spheroid to the center of one well of a 24-well tissue culture dish.

[0304] 7) Incubate in a 37°C incubator for 10-25 minutes.

[0305] 8) Warm a sufficient volume of intestinal organoid growth medium to (15-25°C). Store the remaining medium at 2-8°C.

[0306] 9) Carefully add at least 0.5 mL / well of intestinal organoid growth medium along the sides of the culture wells. Incubate at 37°C, 5% CO2, and 95% humidity.

[0307] 10) Change the culture medium every 3-4 days by aspirating the old medium and adding fresh medium. Incubate at 37°C, 5% CO2, and 95% humidity.

[0308] 11) After 10-14 days of incubation, passage the organoids depending on their growth.

[0309] The micrographs of intestinal organoids after 3, 7, and 12 days of induction differentiation of human pluripotent stem cells / embryonic stem cells in this example are as follows: Figure 1a-2 to Figure 1c-2 shown.

[0310] Comparative Example 1-2

[0311] Referring to the culture method of Example 1-2, 0.8% cellulose ester grafted polylactic acid hydrogel and Matrigel (Corning 354277) were used to culture iPSCs. The results are as follows: Figure 2a-2 、 2b-2 shown.

[0312] Both groups showed clear colony margins, uniform cell size, and a high nuclear-cytoplasmic ratio, indicating optimal stem cell status and an undifferentiated cell state. This suggests that cellulose ester-grafted polylactic acid hydrogel and Matrigel are comparable in stem cell culture performance.

[0313] Comparative Example 2-2

[0314] Referring to the culture method of Example 2-2, the intestinal organoid differentiation induction kit containing 0.3% cellulose ester grafted polylactic acid hydrogel and STEMdiff were used respectively. TMThe micrograph of intestinal organoids 12 days after differentiation of human pluripotent stem cells / embryonic stem cells was shown in Figure 1. Figure 3a-2 、 3b-2 shown.

[0315] Comparing the two groups, both were able to culture mature intestinal organoids containing multiple crypt structures that interconnected to form a mini-intestine with a central intestinal lumen. The kit of the present invention even outperformed the control kit, producing intestinal organoids with a more typical and complex crypt structure.

[0316] Example 3-2

[0317] The operation is the same as that of Examples 1-2 and 2-2, except that the hydrogels are: cellulose acetate grafted polycaprolactone hydrogel, cellulose propionate grafted polyethylene carbonate hydrogel, cellulose butyrate grafted polypropylene carbonate hydrogel, cellulose acetate grafted polydioxanone hydrogel, Figures 4a-2 to 4d-2 These are micrographs of intestinal organoids (12 days) cultured in the above hydrogels.

[0318] The above describes exemplary embodiments of the present invention. However, the scope of protection of this application is not limited to the above embodiments. Any modifications, equivalent substitutions, improvements, etc. made by those skilled in the art within the spirit and principles of the present invention should be included in the scope of protection of the present invention.

Claims

1. A cellulose-based hydrogel formed from a cellulose copolymer, a cellulose derivative copolymer, or a blend thereof, characterized in that: Its matrix includes a cellulose copolymer, a cellulose derivative copolymer or a blend thereof, the matrix includes a network structure composed of ultrafine cellulose derivative fibers, and the network structure includes an ordered three-dimensional micro-nano structure, the cellulose copolymer is a graft copolymer, the cellulose derivative copolymer is a graft copolymer of a cellulose derivative, and the blend contains at least two or more of the above-mentioned cellulose copolymers and cellulose derivative copolymers. Preferably, the cellulose copolymer, cellulose derivative copolymer or a blend thereof is selected from cellulose ester grafted with polylactic acid, cellulose acetate grafted with polycaprolactone, cellulose propionate grafted with polyethylene carbonate, cellulose butyrate grafted with polypropylene carbonate or cellulose acetate grafted with polydioxanone.

2. The cellulose-based hydrogel according to claim 1, characterized in that The diameter of the fiber is 0.01 μm to 0.10 μm, for example, 0.01 μm, 0.02 μm, 0.03 μm, 0.04 μm, 0.05 μm, 0.06 μm, 0.07 μm, 0.08 μm, 0.09 μm or 0.10 μm. Preferably, the overall particle size of the matrix in the hydrogel is 1 μm-50 μm, for example, 1 μm, 5 μm, 8 μm, 10 μm, 15 μm, 20 μm, 25 μm, 30 μm, 35 μm, 40 μm, 45 μm or 50 μm. Preferably, the solid content of the hydrogel is 0.1-3.0 wt%, for example, 0.1 wt%, 0.5 wt%, 1 wt%, 1.5 wt%, 2 wt%, 2.5 wt% or 3.0 wt%.

3. The cellulose-based hydrogel according to claim 1-2, characterized in that The hydrogel is obtained by the following method, including first preparing a cellulose copolymer, a cellulose derivative copolymer or a blend thereof (hereinafter referred to as the product) from cellulose or a cellulose derivative as a raw material, then dispersing the product in pure water, or pouring the product solution into a coagulation bath to form a gel, and crushing the gel by a homogenizer, a colloid mill or a ball mill to obtain the cellulose-based hydrogel having an ordered three-dimensional micro-nanostructure network structure. Preferably, the cellulose raw material includes microcrystalline cellulose, wood pulp cellulose, refined cotton, cotton pulp or wood pulp, or the cellulose raw material or cellulose derivative raw material is dissolved in a cellulose solvent. Preferably, the solvent that can be used in the coagulation bath includes water, ethanol, acetone, ethylene glycol, etc. Preferably, the cellulose solvent, that is, a solvent that can dissolve cellulose, is selected from the ionic liquid and / or NaOH / Urea system; more preferably, the cellulose-dissolving ionic liquid is selected from one or more of [AMIM][Cl], [BMIM][Cl], [EMIM][Ac], and [BMIM][Ac].

4. A method for preparing the cellulose-based hydrogel according to any one of claims 1 to 3, characterized in that: The method comprises the following steps: 1) preparing cellulose copolymers, cellulose derivative copolymers or blends thereof from cellulose or cellulose derivatives as raw materials, hereinafter referred to as products; 2) dispersing the product of step 1) in pure water, or pouring the product solution into a coagulation bath, washing with pure water, and then crushing using a grinder, colloid mill, high-pressure homogenizer, etc. to obtain the cellulose-based hydrogel; Preferably, in step 1), the cellulose includes microcrystalline cellulose, wood pulp cellulose, refined cotton, cotton pulp or wood pulp; Preferably, in step 1), the cellulose is dissolved with a cellulose solvent, and the cellulose solvent is any good solvent known in the art that can dissolve (the dissolving includes complete dissolution and partial dissolution) cellulose; Preferably, the solvent system for dissolving cellulose comprises the ionic liquid and / or the NaOH / Urea system; more preferably, the cellulose-dissolving ionic liquid is selected from one or more of [AMIM][Cl], [BMIM][Cl], [EMIM][Ac], and [BMIM][Ac]; Preferably, in step 1), the cellulose derivative includes cellulose ester, cellulose ether, cationized cellulose, anionized cellulose or oxidized cellulose; Preferably, in step 2), the solvent that can be used in the coagulation bath includes water, ethanol, acetone or ethylene glycol; Preferably, in step 2), a high-pressure sterilization step is further included after the crushing.

5. A 3D cell culture medium, a tissue and organoid culture medium, or a stem cell differentiation-induced organoid culture medium, characterized in that: The culture medium for 3D cell culture includes the cellulose-based hydrogel and the basic culture medium according to claim 1; the cellulose derivative-based culture medium for culturing tissues and organoids includes the cellulose-based hydrogel and the composite culture medium according to claim 1, and the composite culture medium includes the basic culture medium and the active component. Preferably, in every 100 mL of composite culture medium, the mass ratio of the basic culture medium to the active component is 80-99:1-20, for example, 97:3, and more preferably, the composite culture medium contains epidermal growth factor (Epirregulin) 100-500 ng / ml, for example, 200 ng / ml, 300 ng / ml, 400 ng / ml, 500 ng / ml; the stem cell induced differentiation organoid culture medium includes the cellulose-based hydrogel, definitive endoderm differentiation culture medium, MH differentiation culture medium, and organoid growth culture medium according to claim 1.

6. A method for preparing the culture solution according to claim 5, characterized in that: The method for preparing the culture medium for 3D cell culture comprises the following steps: S1: preparing the above-mentioned cellulose-based hydrogel; S2: mixing the cellulose-based hydrogel in step S1 with a basic culture medium to prepare the culture medium for 3D cell culture; Wherein, in step S2, the volume ratio of the cellulose-based hydrogel to the basic culture medium is 1-10:1-10, for example, 1:1, 1:5, 1:10, 5:1 or 10:

1.

7. A method for 3D cell culture, characterized in that: The method for 3D culturing cells is carried out in the 3D cell culture medium according to claim 5, and the 3D culturing method comprises the following steps: a) Preparing a cell suspension: uniformly mixing the 3D cell culture medium with the cells to obtain a cell suspension; b) 3D culture: culturing the cell suspension from step a) in an incubator; Preferably, the cells include human neuroblastoma cells, such as SH-SY5Y cells and hepatoma cells, Preferably, in step b), the culturing time is 1 to 10 days, preferably 3 days.

8. A method for inducing stem cell differentiation into organoids, characterized in that: The method comprises culturing a single stem cell or a stem cell group in the stem cell differentiation-inducing organoid culture medium according to claim 5, wherein the method comprises the following steps: a) iPSC / ES differentiation in monolayer culture, including definitive endoderm differentiation and mid / hindgut (MH) differentiation; b) organoid culture, comprising preparing an organoid growth medium, and mixing the cellulose-based hydrogel of claim 1 with the spheroids and incubating the mixture; Preferably, the definitive endoderm differentiation in step a) includes preparing a definitive endoderm differentiation culture medium and performing definitive endoderm differentiation.

9. A use of the cellulose-based hydrogel according to claim 1 or the culture medium according to claim 5 in 3D cell culture, tissue and organoid culture, or stem cell culture and induced differentiation of organoids, characterized in that: Preferably, the cells include human neuroblastoma cells, such as SH-SY5Y cells and liver cancer cells, such as HepaRG cells. Preferably, the tissue is human gastric cancer tissue / normal gastric tissue, human intestinal cancer tissue / normal intestinal tissue. Preferably, the organoid is human gastric cancer organoid / normal gastric organ, human intestinal cancer organoid / normal intestinal organoid. Preferably, the induced differentiated organoid is, for example, induced differentiated intestinal organoid, gastric organoid, liver organoid, and more preferably small intestinal organoid.

10. A kit, characterized in that The kit comprises the culture medium for 3D cell culture or the culture medium for tissue and organoid culture or the culture medium for stem cell culture and induced differentiation of organoids according to claim 5 and instructions for use.